Notices. Notice of registration
384 words·~2 min read·
/register/2016/12/28/2016-31273·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4410-09-P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Importer of Controlled Substances Registration ACTION: Notice of registration. SUMMARY: Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration
(DEA)as importers of various classes of schedule I or II controlled substances. SUPPLEMENTARY INFORMATION: The companies listed below applied to be registered as importers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices. Company FR docket Published Rhodes Technologies 81 FR 46956 July 19, 2016. Bellwyck Clinical Services 81 FR 54603 August 16, 2016. Cerilliant Corporation 81 FR 57933 August 24, 2016. Noramco, Inc 81 FR 57932 August 24, 2016. Cody Laboratories, Inc 81 FR 54602 August 16, 2016. AMRI Rensselaer, Inc 81 FR 54603 August 16, 2016. ALMAC Clinical Services Incorp
(ACSI)81 FR 54602 August 16, 2016. Fresenius Kabi USA, LLC 81 FR 54601 August 16, 2016. Akorn, Inc 81 FR 57935 August 24, 2016. Actavis Laboratories FL, Inc 81 FR 54602 August 16, 2016. Unither Manufacturing LLC 81 FR 61250 September 6, 2016. Cambrex Charles City 81 FR 63222 September 14, 2016. United States Pharmacopeial Convention 81 FR 63220 September 14, 2016. R & D Systems, Inc 81 FR 64509 September 20, 2016. Catalent CTS, LLC 81 FR 66081 September 26, 2016. The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I or II controlled substances to the above listed persons. Dated: December 19, 2016. Louis J. Milione, Assistant Administrator. [FR Doc. 2016-31273 Filed 12-27-16; 8:45 am]
Connectionstraces to 3
Citation graph
cites case law
Cites 3Cited by 0 across 0 sources